Drug Type Small molecule drug |
Synonyms Mg2+-protoporphyrin IX |
Target |
Action blockers |
Mechanism Nav1.5 blockers(Sodium channel protein type V alpha subunit blockers) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Breast Cancer | Preclinical | Germany | 29 Jan 2026 | |
| Breast Cancer | Preclinical | Germany | 29 Jan 2026 | |
| Colorectal Cancer | Preclinical | Germany | 29 Jan 2026 | |
| Colorectal Cancer | Preclinical | Germany | 29 Jan 2026 |





